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Abstract
Background: Pneumococcus is a major human pathogen and the polysaccharide capsule is considered its main
virulence factor. Nevertheless, strains lacking a capsule, named non-typeable pneumococcus (NT), are maintained in
nature and frequently colonise the human nasopharynx. Interest in these strains, not targeted by any of the currently
available pneumococcal vaccines, has been rising as they seem to play an important role in the evolution of the
species. Currently, there is a paucity of data regarding this group of pneumococci. Also, questions have been
raised on whether they are true pneumococci. We aimed to obtain insights in the genetic content of NT and
the mechanisms leading to non-typeability and to genetic diversity.
Results: A collection of 52 NT isolates representative of the lineages circulating in Portugal between 1997 and
2007, as determined by pulsed-field gel electrophoresis and multilocus sequence typing, was analysed. The
capsular region was sequenced and comparative genomic hybridisation (CGH) using a microarray covering the
genome of 10 pneumococcal strains was carried out. The presence of mobile elements was investigated as
source of intraclonal variation. NT circulating in Portugal were found to have similar capsular regions, of cps type
NCC2, i.e., having aliB-like ORF1 and aliB-like ORF2 genes. The core genome of NT was essentially similar to that
of encapsulated strains. Also, competence genes and most virulence genes were present. The few virulence
genes absent in all NT were the capsular genes, type-I and type-II pili, choline-binding protein A (cbpA/pspC),
and pneumococcal surface protein A (pspA). Intraclonal variation could not be entirely explained by the presence of
prophages and other mobile elements.
Conclusions: NT circulating in Portugal are a homogeneous group belonging to cps type NCC2. Our observations
support the theory that they are bona-fide pneumococcal isolates that do not express the capsule but are
otherwise essentially similar to encapsulated pneumococci. Thus we propose that NT should be routinely
identified and reported in surveillance studies.
Background
Pneumococcus is a major human pathogen, causing a
wide range of infections from otitis media to bacteraemia
and meningitis. Its main virulence determinant is a poly-
saccharide capsule that surrounds pneumococcal cells,
providing protection against phagocytosis [1]. Together
with colony morphology, susceptibility to optochin, and
bile solubility, assignment of a serotype (based on the
capsular type) has been traditionally the ultimate assay
to identify pneumococcus [2]. To date, more than 95
serotypes have been described and, with the exception
of type 37, the genes responsible for the expression of
the capsule are located in the chromosome between
the dexB and aliA genes (capsular region) [1,3]. The
pneumococcal capsule is also the target of all currently
available pneumococcal vaccines [4].
Pneumococci lacking a polysaccharide capsule are
known to exist in nature and are frequent inhabitants of
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the upper respiratory tract of humans [5]. Although these
isolates, often named non-typeable pneumococcus (NT),
are mostly asymptomatically carried in the nasopharynx,
they have also been associated with conjunctivitis out-
breaks and sporadically associated with other disease
manifestations including invasive disease [6-9]. Studies
have suggested, using a combination of phenotypic and
genotypic methods, that some of these isolates are
bona-fide pneumococci and share common properties
with encapsulated pneumococci [5,10]. Also, in vitro
studies with non-encapsulated pneumococci have shown
that these strains display increased adherence to epithelial
tissue, increased capacity for biofilm formation, and are
highly transformable [11-13]. Hence, high carriage rates
combined with high transformability rates may provide
NT with the features needed to play an important role in
the evolution of pneumococcus as recently proposed by
Chewapreecha, et al. [14].
In a previous study, we have described the population
structure of NT strains in Portugal and identified major
lineages associated with them [5]. In parallel, others have
identified the same lineages in circulation in other geo-
graphical settings and the capsular region of NT has
been characterised [10,15-17]. Based on the capsular
region, NT have been proposed to be divided in two
groups: Group I includes isolates with a disrupted or
non-functional capsular locus and Group II includes
isolates with genes not found in conventional capsular
types [17]. Group II NT have been proposed to be fur-
ther divided into cps types NCC1, when isolates have the
pspK gene (pneumococcal surface protein Korea, also re-
ferred to as nspA, non-typeable pneumococcal surface
protein A), encoding for a novel pneumococcal surface
protein with several features suggesting a role in cell adhe-
sion and enhanced colonisation, and NCC2, when isolates
have both the aliB-like ORF1 and aliB-like ORF2 genes,
predicted to encode for lipoproteins [15-18]. A cps type
NCC3 has also been described for isolates with aliB-like
ORF2 but not aliB-like ORF1, but these were shown not
to be pneumococci [15].
The observation that several distinct clonal lineages
lacking the capsule operon have been in circulation for
decades and are not derived from encapsulated strains
has raised the question of how different is the genome
of these strains compared to encapsulated pneumococci
[5,8]. The aim of this study was to characterise a carriage
collection of NT circulating in Portugal in a period of
11 years to obtain insights into the genetic basis of non-
typeability and their genomic content and diversity.
Results
Capsular region of NT
To obtain insights into the genetic basis of non-typeability,
the capsular region was characterised for a set of 42 NT
strains representative of the lineages detected in cross-
sectional colonisation studies conducted in Portugal
among children between 1997 and 2007 (Table 1). Ampli-
fication of this region yielded, in all strains, a fragment of
6,000-8,500 bp. To investigate the heterogeneity of the
capsular region, restriction fragment length polymorphism
(RFLP) patterns were determined by digestion with HinfI.
Nine different patterns could be distinguished after di-
gestion with HinfI (Figure 1, Table 1). We then selected
13 isolates, representative of the different capsular RFLP
patterns found in each CC, for sequencing. The findings
are summarised in Figure 2 that shows a schematic or-
ganisation of the locus compared to strains previously
described by Hathaway, et al. [17]. All strains had aliB-like
ORF1, aliB-like ORF2, and capN-like regions; eight had
the doc-like region between capN-like and aliA. Based on
the classification previously proposed by Park, et al. [15],
the strains were therefore classified as belonging to cps
type NCC2a (eight isolates containing the doc-like region)
or NCC2b (the remaining five isolates). Of the eight
strains belonging to cps type NCC2a, two had an insertion
of a tnp region of ~1.7 kb between dexB and aliB-like
ORF1 previously described [15,16].
Candidate core genome
To determine if the genome content of NT strains is com-
parable to that of encapsulated strains, 34 NT representing
the diversity of profiles identified by PFGE, MLST, and char-
acterisation of the capsular region, were characterised by
CGH using an array that covers the genome of nine encap-
sulated pneumococcal strains and R6 (a non-encapsulated
derivative of D39) (Additional file 1). From the 3,052 genes
present in the array, 1,666 (54.6%) were present in all NT
tested, 839 (27.5%) were present in some, and 547 (17.9%)
were absent in all (Additional file 2). In an independent ana-
lysis, conducted in the framework of an ongoing study, 180
encapsulated strains were analysed by CGH. These strains
were representative of 20 serotypes and included all strains
in the array (except R6). Results from this analysis were used
for comparison. In this collection, 1,654 genes (54.2%) were
present in all strains, the same proportion found for the NT
isolates. Of these 1,654 genes, 1,499 (90.6%) were also
present in all NT isolates (Additional file 2). Among the
remaining 155 genes, 149 were present in some (but not all)
NT and only 6 were absent in all. The proportion of these
155 genes present in the NT strains ranged between 80.0%
and 58.7% (Additional file 3). The 149 genes with variable
presence among NT strains could be grouped into the fol-
lowing functions: 22.8% cellular metabolism, 16.1% trans-
porters, 8.7% DNA metabolism, 7.4% phages and mobile
elements, 2.0% surface proteins, 2.0% signalling and com-
munication, and 41.0% were annotated as hypothetical pro-
teins. The six genes absent in all NT were SP_0346
(annotated as capsular polysaccharide biosynthesis protein
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Table 1 Study collection and characteristics of the strains
CCa Strain Year PFGE MLST Antibiotype
(non susceptible to)b
CSP/ComDc Capsular
region RFLP
Capsular region
sequenced
Analysis
by CGH
344 PT944 2001 NT1 344 PG, Ery, Da, Tet, SXT 2/2 A Yes Yes
LGST142 2000 NT1 344 Ery, Da, Tet, SXT 2/2 A No No
PT191 2001 NT1 344 PG, Ery, Da, Tet, SXT 2/2 A No No
PT3412b 2002 NT1 344 Ery, Da, Tet, SXT 2/nd A No No
PT998 2001 NT1 344 PG, Ery, Tet, SXT 2/nd A No No
LGST214 2000 ND 344 Ery, Tet, SXT 2/nd A No No
DCC2367 1999 NT1 344 PG, Tet, SXT 2/2 F Yes No
PT389 2001 NT1 344 PG, Tet, SXT 2/nd F No No
PT4427a 2002 NT1 344 PG, Ery, Tet, SXT 2/nd H Yes No
WL212 2001 NT1 1619 PG, Ery, Da, SXT 2/2 A No Yes
PT5899 2007 NT1 5220 PG, Ery, Tet, SXT 2/nd nd No Yes
DCC635 1997 NT2 344 PG, Ery, Da, Tet, SXT 2/2 A No Yes
WL992 2002 NT3 344 PG, Ery, Da, Tet, SXT 2/2 A No Yes
PT2987 2002 NT4 344 PG, Ery, Da, Tet, SXT 2/nd A No No
PT2293b 2001 NT4 344 PG, Ery, Da, Tet, SXT 2/2 E Yes Yes
PT6317 2007 NT5 344 PG, Ery, Da, Tet, SXT 2/nd nd No Yes
PT5838b 2007 NT6 344 Ery, Da, Tet, SXT 2/nd nd No Yes
WL1514 2003 NT7 344 PG, Ery, Da, Tet, SXT 2/2 A No Yes
PT6318 2007 NT7 4586 PG, Ery, Da, Tet, SXT 2/nd nd No Yes
PT5269 2006 NT8 344 PG, Ery, Da, Tet, SXT 2/nd nd No Yes
DCC2879 1999 NT9 897 PG, Ery, Da, Tet, SXT 2/2 A No Yes
PT1571b 2001 NT10 344 PG, Ery, Da, Tet, SXT 2/2 A No Yes
PT5727 2006 NT11 344 PG, Ery, Da, Tet, SXT 2/nd nd No Yes
PT5082a 2003 NT22 344 PG, Ery, Da, Tet, SXT 2/nd I No No
WL598 2001 NT25 344 PG, Tet, SXT 2/nd F No No
DCC1795 1998 NT26 1541 PG, Ery, Da, Tet, SXT 2/2 A No Yes
DCC2435p 1999 ND 344 Ery, Da, Tet, SXT 2/nd A No No
1156 PT268 2001 NT21 1156 PG, Ery, Da, Tet, SXT 1/nd A No No
PT6210 2007 NT21 4583 PG, Ery, Da, Tet, SXT 1/nd nd No Yes
PT2687b 2001 NT22 1156 PG, Ery, Da, Tet, SXT 1/nd A No No
PT5561 2006 NT22 1156 PG, Ery, Da, Tet, SXT 1/nd nd No Yes
PT4014 2002 NT22 1153 PG, Ery, Da, Tet, SXT 1/1 C No Yes
PT4222 2002 NT24 1156 PG, Ery, Da, Tet, SXT 1/1 A No No
PT5002 2003 NT24 1156 Ery, Da, Tet 1/1 A No Yes
PT1493 2001 NT24 1617 PG, SXT 1/1 A Yes Yes
WL352.1 2001 NT24 1703 PG, SXT 1/1 A No Yes
PT3201 2002 NT24 1153 PG, Ery, Da, Tet, SXT 1/1 C Yes Yes
PT6209b 2007 NT24 4583 PG, Ery, Da, Tet 1/nd nd No Yes
PT2322 2001 ND 1153 PG, Ery, Da, Tet, SXT 1/nd C No No
320 PT1804b 2001 NT19 888 PG, SXT 1/1 A Yes Yes
1540* PT1718 2001 NT12 1540 SXT 1/4 A Yes Yes
1278* PT4812 2003 NT22 1278 PG, SXT 1/1 A Yes Yes
941 DCC2787 1999 NT13 941 SXT 2/2 B Yes Yes
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Cps4A), SP_0368 (cell wall surface anchor family protein),
SP_1153 (hypothetical protein), SP_2157 (alcohol dehydro-
genase, iron-containing), SP_2158 (L-fucose isomerase),
and SP_2168 (fucose operon repressor, putative).
Furthermore, NT isolates contained between 2,049
and 2,120 genes detected by CGH with an average of
2,095 genes, while the 180 encapsulated strains had
between 2,119 and 2,306 genes with an average of 2,235.
Based on these experiments, although the size of “core”
genomes of NT versus encapsulated strains was
comparable, NT strains characterised in this study had
6.3% less genes detected by CGH than encapsulated
strains.
Accessory regions (ARs)
To further analyse the genome content of NT strains, the
presence of previously identified accessory regions was
investigated (Figure 3) [19]. Of the 41 accessory regions
described to date, 17 were present or partially present in
all NT strains analysed (ARs 3, 6, 9, 13–15, 18, 20–22,
31–33, 35, 37–39) and 7 were absent in all (ARs 2, 5, 7,
11, 30, 36, and 41). Furthermore, 8 ARs were present, or
at least partially present, in most strains (ARs 1, 8, 10,
16, 17, 19, 23, 28) and 9 ARs were absent, or mostly absent,
in most strains (ARs 4, 12, 24–27, 29, 34, and 40).
Twenty-five new ARs (named ARs 42 to 66), totalling
134 genes, were identified in this study. Their predicted
Table 1 Study collection and characteristics of the strains (Continued)
WL165b 2001 NT13 1704 2/2 B No Yes
DCC2648 1999 NT14 941 SXT 2/2 B No Yes
448 WL850a 2002 NT15 448 2/2 B Yes Yes
WL1084 2002 NT15 448 2/2 B No No
PT2417 2001 NT15 448 PG, SXT 2/nd B No No
WL108 2001 NT16 448 2/nd nd No Yes
1618 PT673 2001 NT17 1618 PG, Ery 1/1 D Yes Yes
WL402.1b 2001 NT17 1618 PG, Ery, Da, Tet, SXT 1/1 D No Yes
1705* WL977 2002 NT23 1705 PG, SXT 1/1 G Yes Yes
a – clonal complex (CC); singleton (*); b – penicillin G (PG), erythromycin (Ery), clindamycin (Da), tetracycline (Tet), and trimethoprim sulfamethoxazole (SXT);
c – ComD2 had an E151K substitution and ComD4 had an M77I and an E151K substitutions, both outside the sensor domain of ComD; nd – not determined.
A       I C      E      F            D     G     H      B
5,000bp
2,000bp
1,000bp
500bp
100bp
Figure 1 RFLP patterns of the capsular region of NT strains with HinfI. Capital letters in lanes refer to an arbitrary pattern designation.
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functions are described in Table 2 and include ABC
transporters, type II restriction-modification systems,
phosphotransferase systems and proteins involved in
metabolism, cell envelope, transport, and transcription
regulation. These 25 ARs were dispersed around the
TIGR4 genome (Figure 4). Of these, 22 ARs were present,
or at least partially present, in most strains (ARs 42–54,
56–59, and 61–65), 2 ARs were absent, or mostly absent,
in most strains (ARs 55 and 60), and AR66 (encoding
for hypothetical proteins) was absent in all.
Altogether, when looking for ARs absent in all NT,
these were found to encode for capsular genes (AR7),
type-I pili (AR11), sucrose ABC transporter (AR36), fucose
metabolism (AR41), a putative bacteriocin (AR2), and
several hypothetical proteins (ARs 5, 30 and 66).
Virulence factors
A total of 496 of the genes present on the array were
identified as virulence factors of pneumococcus based
on published data (annotated in Additional file 2) [20-30].
Of these, 363 (73.2%) were present in all NT strains and 36
(7.3%) were absent in all. This latter group included genes
associated with capsular synthesis (TIGR4 cpsA, cpsC,
cpsD, cpsE, cpsF, and cpsJ), pilus islet-1, the virulence pro-
teins cbpA/pspC, pspA, nanE, glf, and ntpK among others
(Additional file 2). PCR analysis of pilus islet-1 and −2
confirmed the absence of these loci in all 52 strains.
Regarding competence-associated genes (n = 22), all
were present in all strains, including the recently described
comG operon (SP_1808 and SP_2047-53), encoding for a
type-IV transformation pilus (Table 3) [31]. In addition,
Figure 2 Schematic representation of the capsular region of NT strains. NCC2a and NCC2b refer to a classification of cps types proposed by
Park, et al. [15]. Published sequences of strains 110.58 [GenBank:AY653211.1], 104.72 [GenBank:AY653210.1], and 106.44 [GenBank:AY653209.1] are
shown for comparative purposes [17]. capN and doc indicate capN-like and doc-like regions, respectively.
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comC and comD alleles were determined by PCR for the 52
NT strains included in this study and a clear distinction be-
tween CCs could be observed for comCD: CCs 344, 448,
and 941 encoded CSP2 and ComD2; CCs 320, 1156, 1278,
1618, and 1705 had CSP1 and ComD1; and CC1540 had
CSP1 and ComD4 [32].
Nine choline binding proteins have been implicated in
virulence, and all were present on the array [20,27,33,34].
Of these, cbpD, cbpE/pce, lytA, lytB, and lytC were present
in all strains, with cbpA/pspC and pspA being absent in all
strains. Variation between CCs was found for cbpF, cbpG
and pcpA (Table 3).
In addition, 12 genes implicated in colonisation were
present on the array. Of these, pavA, eno, pyrR, strH,
trpG, rr01, and SPY2053 were present in all NT, while
rlrA was absent in all strains. Clonal variation was found
for genes hyl, nanA, bgaA, and phoU (Table 3).
Among other major virulence factors, ply, psaA, htrA,
IgA, and spxB were present in all strains with variations
between clones found for the operons piuA-D and piaA-D
and zmpB.
Further details on the variable presence of virulence
genes can be found in Additional file 2.
Intraclonal variation
Comparison of SmaI-PFGE patterns of NT strains resulted
in an unexpected high diversity of profiles for strains
belonging to the same ST (Figure 5) [5]. Likewise, there
were also strains with similar PFGE profiles belonging
to different STs. This lack of concordance was puzzling, as
previous studies have found a good general agreement
with PFGE and MLST for encapsulated pneumococci [35].
To investigate possible genomic variations that could ac-
count for the lack of concordance found between PFGE
and MLST results, CGH results were compared for strains
belonging to the same CC. For any given CC, all strains
analysed shared at least 72% of the genes detected in the
NT pool (Figure 6).
When we looked at intraclonal diversity, within each
CC, variation between strains was mostly due to only a
few (if any) genes. Still, exceptions were found: strains
PT944 of CC344, PT4014 of CC1156, and DCC2787 of
CC941 had 162, 144, and 244 genes, respectively,
uniquely present in their genomes compared to other
strains of the same CC. Also, the two strains of
CC1618 were found to differ from each other in more
than 400 genes.
When looking for the functions of genes uniquely
present in one strain of a given CC, most were found to
encode for hypothetical proteins (51.3%). Other genes
had the following functions: transport and secretion
(13.4%), cell metabolism (9.9%), phages and mobile
elements (9.5%), DNA metabolism (7.8%), cell wall, cell
membrane, and cell division (3.8%), signalling and
communication (2.7%), and stress (1.5%). Furthermore,
only 10.2% of this latter group of genes have been described
as virulence genes. Not surprisingly, close to half of these
genes were found in ARs (44.4%).
Figure 3 Distribution of accessory regions (ARs) among NT strains. Dark yellow – AR is present; light yellow – more than 50% of the genes
in the AR are present; white – 50% of the genes in the AR are present; light blue – more than 50% of the genes in the AR are absent; dark
blue – AR is absent.
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To investigate if the high variability of PFGE types
found could be due to the presence of prophages, as
previously reported [36], or the presence of other mo-
bile elements, we evaluated their distribution among
NT strains (Figure 7). In some cases, e.g. NT1, NT2,
and NT6 of ST344 or NT22 and NT24 of ST1153, the
content of mobile elements was indeed distinct between
strains, which might explain the variability found. How-
ever, in other cases, such as NT2, NT3, NT5, NT8, and
NT11 of ST344 and NT15 and NT16 of ST448, the
strains shared the same mobile elements. On the other
hand, examples of strains belonging to the same PFGE
type and ST but with different mobile elements’ profiles
were also observed (e.g. NT17 of ST448). To complement
this analysis, the presence of prophages was also deter-
mined by lytA hybridisation (Additional file 4). In ST344,
the six PFGE types tested exhibited three lytA hybridisa-
tion patterns, whereas the two ST448 PFGE types tested
showed the same lytA hybridisation pattern. According to
these results, the high variability of PFGE types observed
within STs could not be entirely explained by the presence
of prophages or other mobile elements.
Discussion
In this study we aimed to characterise the genomic content
of a collection of NT strains representative of the carriage
lineages circulating in Portugal in a period of 11 years
(1997–2007). Strains were analysed by CGH against a panel
of 10 pneumococcal strains and their capsular region was
sequenced. According to their capsular regions, strains in
this study could be classified as NCC2, as they all contained
aliB-like genes [15]. Strains with similar capsular regions
have also been identified in carriage and disease isolates cir-
culating in Switzerland, the Netherlands, UK, USA, Brazil,
South Korea, Thailand, and the Gambia [15-17,37]. In our
collection we did not find isolates of cps type NCC1
(containing the pspK/nspA gene) and we did not include
NT strains derived from encapsulated lineages that had
alterations in the capsular operon leading to absence of
capsular production (Group I NT).
Table 2 New accessory regions found in NT strains
Accessory region TIGR4 locus Identified by STMa Predicted functionb
42 SP_0115-0117 Yes Cell envelope
43 SP_0124-0126 No Hypothetical
44 SP_0130-0144 Yes ABC transporter (glucose)
45 SP_0314-0330 Yes PTS system
46 SP_0367-0369 No Cell envelope
47 SP_0391-0393 No Cell envelope
48 SP_0569-0571 Yes Type II RM system
49 SP_0595-0597 Yes Hypothetical
50 SP_0627-0629 No Hypothetical
51 SP_0636-0640 No ABC transporter
52 SP_0683-0685 No Hypothetical
53 SP_0703-0711 No ABC transporter (aa)
54 SP_0737-0740 No Transport & transcription regulation
55 SP_1030-1040 Yes ABC transporter (iron)
56 SP_1042-1045 Yes Metabolic
57 SP_1119-1125 Yes Metabolic (glycogen)
58 SP_1160-1165 No Metabolic (acetoin)
59 SP_1209-1211 No Hypothetical
60 SP_1656-1658 No Hypothetical
61 SP_1677-1679 No Hypothetical
62 SP_1849-1851 No Type II RM system
63 SP_1855-1859 Yes Transport & transcription regulation
64 SP_1869-1872 Yes ABC transporter (iron)
65 SP_2147-2154 No Metabolic (arginine)
66 SP_2178-2183 Yes Hypothetical
a – gene(s) within region(s) identified by signature-tagged mutagenesis as required for invasive disease [20]; b – ATP-binding cassette (ABC); phosphotransferase
(PTS); restriction modification (RM); amino acid (aa).
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Of interest, a recent study by Park, et al. aimed to
characterise invasive NT strains from the USA. The
authors reported that these strains are rare, accounting
for less than 1% of the invasive pneumococcal disease
cases, and most are of Group I NT, with only a few cases
caused by NCC2 NT. Nonetheless, it has been clearly
demonstrated that NCC2 NT are capable of causing
invasive disease and therefore should not be disre-
garded [17,37].
In relation to core genome, 54.6% of the genes repre-
sented on the array were found in all NT strains, the same
proportion found for a collection of 180 encapsulated
strains used for comparison (54.2%). However, the average
number of total genes detected in the NT strains (2,095)
was 6% less than the corresponding value found for en-
capsulated strains. Still, this result should be interpreted
with caution as, by using a CGH approach, NT genes were
probably missed to an unknown extent.
Twenty-five new ARs, dispersed around the TIGR4
genome, were identified in this study. Of the 66 ARs
identified to date, only seven were absent in all NT and
encoded for genes associated with sugar metabolism,
capsular synthesis, type-I pilus, and hypothetical pro-
teins [19]. Also, more than 90% of the virulence factors
identified in pneumococcus were found in NT. The
most relevant virulence factors absent from all NT were
the capsular genes and type-I pilus (referred to above),
type-II pilus, choline-binding protein A (cbpA/pspC),
and pneumococcal surface protein A (pspA) [23]. Also
absent in the majority of NT was the major iron ABC
transport system piaA-D. However, piuA-D, a second
iron ABC transport system, was present in the majority
of NT. Mutations in these systems have been shown to
result in mild (piuA-D) to moderate (piaA-D) reduction
in virulence [38]. Together with the lack of capsule and
other important virulence genes, the absence of these
genes in NT should contribute to a lower propensity of
NT to cause disease.
As expected, all strains had all competence genes, includ-
ing the newly described transformation pilus [14,31,39]. Ac-
cording to the type of competence stimulating peptide
(CSP, encoded by comC) secreted by pneumococcal strains,
strains can be divided in pherotypes. The dominant
pneumococcal pherotypes are CSP1 and CSP2, respectively
found in 60-75% and 25-40% of carriage or clinical isolates
[40,41]. In NT, the dominant pherotype was CSP2 (65% of
the strains), with the remaining strains belonging to pher-
otype CSP1. In our study, pherotype was a clonal property,
with all strains within a CC belonging to the same phero-
type. The same association was previously observed in
encapsulated pneumococcus [42]. These results further
support that NT are bona-fide pneumococci, in contrast
with atypical strains of ambiguous speciation, where mul-
tiple ComC alleles can be found [43].
To explore the reasons underlying the observation that
NT had highly variable PFGE profiles in contrast to
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Figure 4 Distribution of 66 accessory regions (ARs) over the TIGR4 genome. Bold – new ARs identified in NT strains.
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Table 3 Virulence factors determined by CGH for NT clonal complexes
Gene name and/or annotation CC344
(n = 15)
CC1156
(n = 8)
CC320
(n = 1)
sing1540
(n = 1)
sing1278
(n = 1)
CC941
(n = 3)
CC448
(n = 2)
CC1618
(n = 2)
sing1705
(n = 1)
Competence proteins
comA; competence factor transporting ATP-binding/
permease protein ComA
1 1 1 1 1 1 1 1 1
comB; competence factor transport protein ComB 1 1 1 1 1 1 1 1 1
comD; putative sensor histidine kinase ComD 1 1 1 1 1 1 1 1 1
comE; response regulator ComE 1 1 1 1 1 1 1 1 1
comX1; transcriptional regulator ComX1 1 1 1 1 1 1 1 1 1
competence damage-inducible protein A 1 1 1 1 1 1 1 1 1
coiA; competence protein CoiA 1 1 1 1 1 1 1 1 1
competence protein ComF, putative 1 1 1 1 1 1 1 1 1
celA; competence protein CelA 1 1 1 1 1 1 1 1 1
celB; competence protein CelB 1 1 1 1 1 1 1 1 1
ccs1; competence-induced protein Ccs1 1 1 1 1 1 1 1 1 1
ccs4; competence-induced protein Ccs4 1 1 1 1 1 1 1 1 1
ccs16; competence-induced protein Ccs16 1 1 1 1 1 1 1 1 1
cspC-related protein, authentic point mutation 1 1 1 1 1 1 1 1 1
pilD; type IV prepilin peptidase, putative 1 1 1 1 1 1 1 1 1
comGA/cglA; competence protein CglA 1 1 1 1 1 1 1 1 1
comGB/cglB; competence protein CglB 1 1 1 1 1 1 1 1 1
comGC/cglC; competence protein CglC 1 1 1 1 1 1 1 1 1
comGD/cglD; competence protein CglD 1 1 1 1 1 1 1 1 1
comGE 1 1 1 1 1 1 1 1 1
comGF 1 1 1 1 1 1 1 1 1
comGG 1 1 1 1 1 1 1 1 1
Choline-binding proteins
cbpA/pspC; choline binding protein A 0 0 0 0 0 0 0 0 0
cbpD; choline binding protein D 1 1 1 1 1 1 1 1 1
cbpE/pce; choline binding protein E 1 1 1 1 1 1 1 1 1
cbpF; choline binding protein F 0.1 0.9 1 0 1 0.3 0 0 1
cbpG; choline binding protein G 0.9 1 1 1 1 1 1 1 1
lytA; autolysin 1 1 1 1 1 1 1 1 1
lytB; endo-beta-N-acetylglucosaminidase 1 1 1 1 1 1 1 1 1
lytC; beta-N-acetylhexosaminidase 1 1 1 1 1 1 1 1 1
pspA; pneumococcal surface protein A 0 0 0 0 0 0 0 0 0
pcpA; choline binding protein PcpA 0.9 0.1 0 0 0 0 0 0 0
Colonisation-associated proteins
hyl; hyaluronidase 0.9 1 1 1 1 1 1 0.5 1
nanA; neuraminidase A/siliase A precursor 0.1 0 0 1 0 0 0 0.5 1
pavA; adherence and virulence protein A 1 1 1 1 1 1 1 1 1
rlrA; transcriptional regulator, putative 0 0 0 0 0 0 0 0 0
bgaA; beta-galactosidase 0.1 0.9 1 0 1 0.3 0 0 0
eno; phosphopyruvate hydratase 1 1 1 1 1 1 1 1 1
pyrR; bifunctional pyrimidine regulatory protein PyrR
uracil phosphoribosyltransferase
1 1 1 1 1 1 1 1 1
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relatively conserved STs, we assessed whether the presence
of prophages or other mobile elements could account for
these observations. Although that seemed to be the case in
some strains, the presence of these mobile elements could
not entirely explain the variability found in NT isolates, at
least with the approaches that were used. A more detailed
characterisation of phage presence, such as the prophage
typing system proposed by Romero, et al., could have
provided additional information but was beyond the
purpose of this study [44,45].
Our study has a major limitation. Information obtained
by CGH is restricted to what is present in the array and
Table 3 Virulence factors determined by CGH for NT clonal complexes (Continued)
strH; beta-N-acetylhexosaminidase 1 1 1 1 1 1 1 1 1
trpG; anthranilate synthase component II 1 1 1 1 1 1 1 1 1
phoU; phosphate transport system regulatory protein
PhoU, putative
0.1 0.9 1 1 1 0.3 0 0.5 0
rr01; DNA-binding response regulator 1 1 1 1 1 1 1 1 1
transcriptional regulator SPY2053 1 1 1 1 1 1 1 1 1
Other major virulence factors
ply; pneumolysin 1 1 1 1 1 1 1 1 1
psaA; manganese ABC transporter, manganese-binding
adhesion lipoprotein
1 1 1 1 1 1 1 1 1
htrA; serine protease 1 1 1 1 1 1 1 1 1
IgA; immunoglobulin A1 protease 1 1 1 1 1 1 1 1 1
spxB; pyruvate oxidase 1 1 1 1 1 1 1 1 1
piaA; iron-compound ABC transporter, iron
compound-binding protein
0.1 0.9 0 0 0 0.3 0 0.5 1
piaB; iron-compound ABC transporter, permease protein 0.1 0.9 0 0 0 0.3 0 0.5 1
piaC; iron-compound ABC transporter, permease protein 0.1 0.9 0 0 0 0.3 0 0.5 1
piaD; iron-compound ABC transporter, ATP-binding protein 0.1 0.9 0 0 0 0.3 0 0.5 1
piuA; iron-compound ABC transporter,
iron-compound-binding protein
1 1 1 1 1 1 1 1 0
piuB; iron-compound ABC transporter, permease protein 1 1 1 1 1 1 1 1 0
piuC; iron-compound ABC transporter, permease protein 1 1 1 1 1 1 1 1 0
piuD; iron-compound ABC transporter, ATP-binding protein 1 1 1 1 1 1 1 1 0
zmpB; zinc metalloprotease 0 0.8 0 0 0 0.3 0 0 1
CC – clonal complex; sing – singleton; numbers between 0 and 1 indicate the relative proportion of strains containing the gene.
10
0
90807060
% similarity
ST344 CC344
NT11
NT6
NT8
NT7
NT9
NT1
NT3
NT26
NT4
NT2
NT5
ST344
ST1156
ST1278
NT10
NT22
CC344
CC1156
S1278
PFGE MLST CC
Figure 5 Comparison of PFGE patterns found for clonal complex (CC) 344, CC941, CC448, and CC1156. Dendrogram generated by
UPGMA and Dice similarity with an optimisation of 1% and a tolerance of 1.5%. CC – clonal complex; S – singleton.
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therefore limited by nature. Still, interesting information
regarding variability and presence/absence of pneumococ-
cal genes implicated in virulence was obtained, providing
further hypothesis related to the low disease capacity of
these strains. Our study has also some strengths. The
thorough characterisation of a representative collection
of NT circulating in Portugal for over a decade provided
insight on the most frequent features of the lineages in
circulation and definitely supported the inclusion of these
strains as part of the pneumococcal population.
Conclusions
NT circulating in Portugal are a homogeneous group be-
longing to cps type NCC2. Our observations support
that this group are bona-fide pneumococcal isolates that
do not express the capsule but are otherwise essentially
similar to encapsulated pneumococci, having a com-
parable core genome and most virulence factors. Given
that NT are not targeted by current pneumococcal
vaccines and that they are highly transformable, we
recommend that these isolates are routinely identified
and reported in surveillance studies monitoring pneumo-
coccal serotype evolution.
Methods
Ethics statement
Approval for the original studies [5,46,47] was obtained
from the Ministry of Education. The studies were regis-
tered and approved at the Health Care Centre of Oeiras
that reports to Administração Regional de Saúde (ARS;
“Regional Health Administration”) of Lisboa and Vale do
Tejo from the Ministry of Health. Signed informed con-
sent was obtained from parents/guardians of participating
children. All samples were coded numerically upon collec-
tion and processed anonymously. In the present study,
only bacterial isolates were characterised (no human sub-
jects, human material or human data were used). Thus,
ethical approval was not required.
Study collection
We selected 52 NT strains for detailed characterisation.
This collection was extracted from a total of 422 NT
Figure 6 Intraclonal diversity of NT strains. CC – clonal complex; numbers in the centre represent the number of genes shared by all strains
of a given CC/singleton and the percentage in relation to the total number of genes detected for NT; other numbers represent the number of
genes found exclusively for a given strain in comparison with strains from the same CC.
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strains isolated between 1997 and 2007 from the nasophar-
ynx of preschool children attending day-care centres in
Lisbon, Portugal. The isolates were previously characterised
by PFGE, MLST, and antibiotic susceptibility to penicillin,
amoxicillin, ceftriaxone, erythromycin, clindamycin, tetra-
cycline, chloramphenicol, and trimethoprim sulfameth-
oxazole (SXT) [5,46,47]. The 52 strains characterised in
this study were selected to cover the diversity of profiles
observed among the 422 isolates, as determined by PFGE,
MLST and antibiotyping. CCs were defined based on goe-
BURST classification [48].
DNA extraction
Total genomic DNA was isolated using either the DNeasy
Blood & Tissue kit (Qiagen, Hilden, Germany), or the High
Pure PCR Template Preparation kit (Roche Diagnostics
GmbH, Mannheim, Germany), according to the manufac-
turers' recommendations.
Characterisation of the capsular (dexB-aliA) region
The dexB-aliA region, corresponding to the capsular
region in encapsulated pneumococci, was amplified by
PCR using the primers described by Kilian, et al. using
the following conditions: 92°C for 2 min; 30 cycles of 92°C
for 10 sec, 58°C for 30 sec, and 68°C for 15 min; and a
final extension at 68°C for 7 min [49]. For a final volume
of 50 μL, the PCR mixture contained 20 ng of DNA, 1x
Expand Long Template buffer 3 with 2.75 mM MgCl2
(Roche), 3.2 mM (each) deoxynucleoside triphosphates,
0.4 mM of each primer, and 3.75U of Expand Long
Template enzyme mix (Roche). Amplicons were purified
using ExoSAP by incubating 30 μL of the PCR product
with 6U of Exonuclease I (New England Biolabs, Ipswich,
MA, USA) and 6U of Shrimp Alkaline Phosphatase (GE
Healthcare, Waukesha, WI, USA) for 30 min at 37°C
followed by 15 min at 80°C.
RFLP signatures of the capsular region were determined
after digestion of 15 μL of purified PCR fragments with
HinfI or StyI for 3 h at 37°C. For a total volume of 20 μL,
5U of enzyme, 1x NEBuffer (New England Biolabs), and
2 μg of BSA (for StyI) were added. Results were analysed
by gel electrophoresis and Bionumerics software (version
3.0, Applied Maths, Gent, Belgium). Patterns were clus-
tered by UPGMA and a dendrogram was generated from
a similarity matrix calculated using the Dice similarity
coefficient with an optimisation of 0.5% and a tolerance of
1.0%. RFLP patterns determined by digestion with HinfI
were arbitrarily named A to H.
Sequencing of the capsular region of representative
RFLP patterns was performed by primer walking. Primers
were designed using the nucleotide sequence of strain
110.58 as a template [GenBank:AY653211.1] (Additional
file 5) [17,49]. PCR products were obtained, purified, and
sent to Macrogen, Inc. (Seoul, South Korea) for se-
quencing. Additional primers were designed to amplify
and sequence the gaps between fragments as needed.
5071S8721S0451S023CC
5071TS4071TS8721TS0451TS888TS3071TS7161TS1451TS798TS6854TS0225TS9161TS
NT1 NT2 NT3 NT4 NT5 NT6 NT7 NT8 NT10 NT11 NT1 NT1 NT7 NT9 NT26 NT22 NT24 NT22 NT24 NT21 NT24 NT24 NT24 NT19 NT12 NT13 NT14 NT13 NT15 NT16 NT17 NT17 NT23
conjugative transposon (membrane) proteins 
HK97 family, phage major capside protein and portal protein
IS116/IS110/IS902 family transposase (degenerate)
IS1167 transposase 
IS1239
IS1380-Spn1 transposase
IS1381
IS1515, transposase, authentic frameshift
IS200S transposase (interruption)
IS30 family transposase (degenerate)
IS3-Spn1 transposase
IS66 family Orf1
lj965 prophage protein 
mobilisation protein A
PblB 
phage antirepressor protein 
phage head morphogenesis protein, SPP1 gp7 family domain 
protein 
phage head-tail adaptor (putative)
phage holin, LL-H family 
phage integrase/recombinase, phage integrase family
phage major tail protein
phage major tail protein, phi13 family
phage minor capsid family proteins
phage portal protein, SPP1 family 
phage protein, Gp19/Gp15/Gp42 family protein
phage recombination protein Bet 
phage replication protein
phage replisome organiser, N-terminal region (putative)
phage scaffold protein
phage structural protein
phage terminase family protein
phage terminase, large subunit, PBSX family
phage transcriptional regulator, ArpU family
phage transcriptional regulator, Cro/CI family 
plasmid addiction system poison protein
platelet-binding phage protein (putative)
prophage Lambda Sa04, tail tape measure protein
prophage Lambda Sa05, DNA primase, P4 family
resolvase, N-terminal domain
site-specific recombinase, phage integrase family 
Spn1 transposase 
tail protein 
terminase large (G2P) and small (G1P) subunits
Tn5251 FtsK/SpoIIIE family protein 
Tn5251 hypothetical protein 
Tn5252 (Orf9, Orf10, and relaxase)
Tn5253 conserved hypothetical protein 
ST941 ST448 ST1618Mobile element
CC344 8161CC844CC149CC6511CC
ST344 ST1156 ST1153 ST4583
NT22
Figure 7 Intraclonal variability of mobile elements. NT1 to NT24 refer to PFGE patterns. Yellow – present; blue – absent.
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Sequences were analysed and aligned using the Lasergene
software (DNASTAR Inc., Madison, WI, USA). Nucleotide
sequences of the capsular region were further analysed by
performing a nucleotide BLAST search at the National
Center for Biotechnology Information Website against the
nucleotide database and also against the capsular region
sequences previously described for NT strains [15-17,50].
CGH
Microarrays used in this study were 12x135K NimbleGen
arrays (Roche). Labelling, hybridisation, and washing of
the samples was done as recommended by the manufac-
turer using a NimbleGen microarray workflow (Roche):
1 μg of DNA from each strain was fluorescently labelled
with Cy3 Random Nonamers using the NimbleGen One-
Color DNA Labeling kit, samples were hybridised to the
microarray slide using the NimbleGen Hybridization
System, slides were washed using the NimbleGen Wash
Buffer kit, and CGH data was acquired on a NimbleGen
MS 200 Scanner. Normalisation and background correc-
tion of data was done by quantile RMA analysis using the
ArrayStar software (DNASTAR). A cut-off of 512 was
reached by drawing a graph of frequencies of signal inten-
sities for all strains. Genes with signal intensities of 512 or
above were considered present (assigned 1) and genes
with signal intensities bellow that value were considered
absent (assigned −1) from a given strain.
Validation of the microarray
The microarray used was designed based on the genome se-
quence of 10 pneumococcal strains: TIGR4, R6, D39,
BHN100, CBR206, LGST215, BHN191, BHN418, Sp14-
BS69, and Sp3-BS71 [51-58]. Triplicates of probes represent-
ing genes present in these strains were added sequentially
resulting in 3,052 non-redundant ORFs. Nine of the 10
strains represented in the array were hybridised with it for
validation. Only 16 of 3,052 (0.52%) ORFs present in the
microarray gave false negative results (Additional file 6).
Most of these genes encoded for hypothetical proteins or
mobile elements that might have been lost (during repeated
handling). None of the 16 genes were part of the core gen-
ome, were related to virulence or located in ARs.
ARs
The presence of ARs (or regions of diversity) previously
identified (reviewed in [19]) was investigated for NT
strains. New ARs were identified as defined by Tettellin
and Hollingshead: three or more contiguous genes in the
TIGR4 genome that were absent from at least one of the
analysed strains [59]. Classification of new ARs followed
the nomenclature proposed by Blomberg, et al. and was
done sequentially [59].
Detection and characterisation of genes by PCR
The presence of genes comC, comD, and piaA and the
presence of type-I and type-II pili was assessed by PCR
and characterised by sequencing when needed. ComD was
amplified using primers comD_F (ATTAAAGGTGGGG
AGATGAGG) and comD_R (CCAGCATAATCATG
TCG), designed with TIGR4 [GenBank:NC_003028.3)
and R6 [GenBank:NC_003098.1] nucleotide sequences
as templates. Amplicons with an expected size of
841 bp were amplified using the following conditions:
94°C for 4 min; 30 cycles of 94°C for 30 sec, 55°C for
30 sec, and 72°C for 1 min; and a final extension at 72°C
for 4 min. For a final volume of 50 μL, the PCR mixture
contained 1 μL DNA, 1x Colorless GoTaq Flexi buffer
(Promega, Madison, WI, USA), 2.5 mM MgCl2, 80 μM
(each) deoxynucleoside triphosphates, 0.4 mM of each
primer, and 2.5U of GoTaq DNA polymerase. Amplicons
were purified using ExoSAP as described above, sent to
Macrogen for sequencing, and analysed by using Laser-
gene software. The presence of comC was assessed as
described by Whatmore, et al. or Carrolo, et al. [40,60];
the presence of piaA was assessed as described by
Whalan, et al. [61], and the presence of type-I and
type-II pili as described by Zahner, et al. [62].
Prophage detection by southern hybridisation of PFGE
restriction profiles with a lytA probe
Preparation of chromosomal DNA, digestion with SmaI
endonuclease, and separation of DNA fragments by PFGE
were carried out as previously described [63]. Southern
blotting of PFGE gels with a probe for the lytA gene was
performed as previously described [36].
Availability of supporting data
Microarray data supporting the results of this article have
been submitted to NCBI Gene Expression Omnibus (GEO)
archive repository [64]. The GEO Series Accession Number
is GSE58329.
Additional files
Additional file 1: Strains represented in the array.
Additional file 2: Core genome, virulence genes, and accessory
regions. a – annotations for: TIGR4 (SP_), D39 (SPN_), R6 (spr), CBR206
(CBR206_), LGST215 (DCCPN215_), Sp3-BS71 (SP3_), Sp14-BS69 (SP14_),
BHN100 (BHN100_), BHN191 (BHN191_), and BHN418 (BHN418_);
Red – genes present in all NT strains analysed; bold – new accessory
regions identified in NT strains.
Additional file 3: Percentage of the 155 genes absent in some NT
but present in a group of 180 diverse encapsulated strains (see
text). ST – multi-locus sequence type; CC – clonal complex.
Additional file 4: Detection of prophages by lytA hybridisation.
A – SmaI-PFGE patterns of strains representing ST344 and ST448;
B – southern blotting of the PFGE gel with a probe for lytA.
Additional file 5: Primers used to amplify the capsular region of NT
strains.
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Additional file 6: Validation of the microarray. a – R6 is a derivative
of D39 and was not hybridised.
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